DK0708657T3 - Sammensætninger til nasal administration af desmopression - Google Patents

Sammensætninger til nasal administration af desmopression

Info

Publication number
DK0708657T3
DK0708657T3 DK94920618T DK94920618T DK0708657T3 DK 0708657 T3 DK0708657 T3 DK 0708657T3 DK 94920618 T DK94920618 T DK 94920618T DK 94920618 T DK94920618 T DK 94920618T DK 0708657 T3 DK0708657 T3 DK 0708657T3
Authority
DK
Denmark
Prior art keywords
composition
nasal administration
container
assembly
desmopression
Prior art date
Application number
DK94920618T
Other languages
Danish (da)
English (en)
Inventor
Alan Harris
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK0708657T3 publication Critical patent/DK0708657T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK94920618T 1993-06-29 1994-06-22 Sammensætninger til nasal administration af desmopression DK0708657T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29
PCT/SE1994/000623 WO1995001183A1 (en) 1993-06-29 1994-06-22 Compositions for nasal administration of desmopressin

Publications (1)

Publication Number Publication Date
DK0708657T3 true DK0708657T3 (da) 2001-10-15

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94920618T DK0708657T3 (da) 1993-06-29 1994-06-22 Sammensætninger til nasal administration af desmopression

Country Status (20)

Country Link
US (1) US5498598A (es)
EP (1) EP0708657B1 (es)
JP (1) JPH09502425A (es)
KR (1) KR100193104B1 (es)
CN (1) CN1101701C (es)
AT (1) ATE203412T1 (es)
CA (1) CA2166312C (es)
CZ (1) CZ282456B6 (es)
DE (1) DE69427820T2 (es)
DK (1) DK0708657T3 (es)
ES (1) ES2158898T3 (es)
GR (1) GR3036936T3 (es)
HK (1) HK1000906A1 (es)
HU (1) HU221617B1 (es)
NZ (1) NZ268442A (es)
PL (1) PL176317B1 (es)
PT (1) PT708657E (es)
RU (1) RU2135204C1 (es)
SK (1) SK282844B6 (es)
WO (1) WO1995001183A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
DK0710243T3 (da) * 1993-06-29 2000-10-16 Ferring Bv Syntese af cykliske peptider
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
DK1530967T3 (da) * 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
EP3225249B1 (en) 2008-05-21 2018-11-07 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
WO2010075327A1 (en) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Desmopressin composition
SG172344A1 (en) 2008-12-22 2011-07-28 Allergan Inc Intranasal desmopressin administration
CA2765221C (en) * 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
WO2016102952A1 (en) 2014-12-22 2016-06-30 Aluztra Bio Ltd Prevention and treatment of metastatic disease in thrombocytotic cancer patients
WO2024105521A1 (en) * 2022-11-17 2024-05-23 Shilpa Medicare Limited Stable peptide pharmaceutical composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
EP0381345B1 (en) * 1989-01-30 1994-07-13 Corint, Ltd. Aqueous liquid desmopressin-CMC pharmaceutical composition
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.

Also Published As

Publication number Publication date
CN1126439A (zh) 1996-07-10
PL312204A1 (en) 1996-04-01
SK165095A3 (en) 1996-11-06
ATE203412T1 (de) 2001-08-15
RU2135204C1 (ru) 1999-08-27
CA2166312A1 (en) 1995-01-12
KR100193104B1 (ko) 1999-06-15
EP0708657B1 (en) 2001-07-25
ES2158898T3 (es) 2001-09-16
NZ268442A (en) 1996-09-25
CN1101701C (zh) 2003-02-19
CA2166312C (en) 2002-04-23
HU221617B1 (hu) 2002-12-28
EP0708657A1 (en) 1996-05-01
PT708657E (pt) 2001-11-30
DE69427820D1 (de) 2001-08-30
CZ282456B6 (cs) 1997-07-16
HU9503833D0 (en) 1996-02-28
PL176317B1 (pl) 1999-05-31
US5498598A (en) 1996-03-12
HK1000906A1 (en) 2002-03-08
WO1995001183A1 (en) 1995-01-12
HUT73776A (en) 1996-09-30
KR960703339A (ko) 1996-08-17
CZ339095A3 (en) 1996-09-11
DE69427820T2 (de) 2001-11-08
JPH09502425A (ja) 1997-03-11
SK282844B6 (sk) 2002-12-03
GR3036936T3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DK0708657T3 (da) Sammensætninger til nasal administration af desmopression
KR960703340A (ko) 안정화된 약학적 펩티드 조성물
PL316689A1 (en) Anti-dandruff shampoo
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
MD1699F2 (ro) Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
ES2139360T3 (es) Preparaciones de suspensiones de peptidos o proteinas.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
AU3183389A (en) Human relaxin formulation
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
AU6414498A (en) Composition comprising immunoglobulin
MX9701170A (es) Composicion antitranspirante en aerosol con poco propulsor.
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
MX9703024A (es) Cristalizacion de levobupivacaina y sus analogos.
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
BG102780A (en) Nasal application of agents for the treatment of delayed emesis fits
HK1006282A1 (en) Novel liquid compositions based on derivatives of 1, 4 substituted piperidine
ES2106680A1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
MX9703839A (es) Soluciones intravenosas de lubeluzol.
CA2187030A1 (en) Improved anti-dandruff shampoo
IT1263107B (it) Composizioni galeniche a base di calcitonina stabilizzate
JO1843B1 (en) Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy